Alexander Bick
Director, Division of Genetic Medicine and Clinical Pharmacology · Vanderbilt University Medical Center
Credentials: · · · · ·
History
- 2019–2020
Medical and Population Genetics
- 2012–2016
Research
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
New England Journal of Medicine · 2017 · 2,232 citations
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
New England Journal of Medicine · 2016 · 1,054 citations
Journal of the American College of Cardiology · 2016 · 769 citations
95 papers · 4 as a fellow
41 papers
37 papers
30 papers
28 papers
- MH
28 papers · 7 as a fellow
25 papers · 17 as a fellow
24 papers
Grants
- 2025–2030
Modelling the Dynamics of Spontaneous Clonal Hematopoiesis in Pet Dogs During Cancer Therapy
National Cancer Institute · R01
PI · $1.4M · Tufts University Boston
- 2024–2029
Vanderbilt Genomic Learning Health System Clinical Site
National Human Genome Research Institute · U01
PI · $2.2M · Vanderbilt University Medical Center
- 2024–2029
Clonal Hematopoiesis Aging Resiliency Mechanisms
National Institute on Aging · R01
Contact PI · $6.6M · Vanderbilt University Medical Center
- 2023–2028
National Institute on Aging · R01
Contact PI · $2.8M · Vanderbilt University Medical Center
Clinical trials
- 2020–2031
The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository
Principal investigator · Recruiting
Vanderbilt-Ingram Cancer Center
- 2026–2030